Publicaciones en colaboración con investigadores/as de Leiden University Medical Center (11)

2022

  1. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects: A Lipidomic Analysis of the VOHF Study

    Molecular Nutrition and Food Research, Vol. 65, Núm. 9

2020

  1. The Aging Imageomics Study: rationale, design and baseline characteristics of the study population

    Mechanisms of Ageing and Development, Vol. 189

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2016

  1. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis

    Journal of Hepatology, Vol. 65, Núm. 5, pp. 914-920

2014

  1. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    Molecular Cancer, Vol. 13, Núm. 1

2011

  1. Pathway-Based analysis of a Melanoma Genome-Wide association study: Analysis of genes related to Tumour-Immunosuppression

    PLoS ONE, Vol. 6, Núm. 12

2007

  1. Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents

    Journal of Medical Genetics, Vol. 44, Núm. 2, pp. 99-106

2006

  1. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL

    Cancer Research, Vol. 66, Núm. 20, pp. 9818-9828